Trial Profile
Safety and efficacy of janagliflozin in patients with type 2 diabetes mellitus
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 12 Nov 2014
Price :
$35
*
At a glance
- Drugs Janagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; First in man
- 12 Nov 2014 New trial record
- 31 Oct 2014 According to a company media release, Sihuan has filed an IND with the CFDA for janagliflozin.